Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Perinatol ; 29(4): 301-6, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22105439

RESUMEN

We examined the relationship between type of skin incision at time of cesarean delivery and postoperative wound complications in the obese parturient. Women with a body mass index (BMI) of greater than 29 who had undergone cesarean delivery at The University of North Carolina were identified from the Pregnancy, Infection and Nutrition study. Inpatient and outpatient medical records were reviewed for maternal demographics as well as intrapartum and intraoperative characteristics. The exposure of interest was type of incision, classified as vertical or transverse. The primary outcome was wound complication, defined as partial or complete wound separation. Logistic regression analysis was used to create a final model of risk factors for wound complications while controlling for potentially confounding variables. From 1998 to 2005, 238 women with a BMI greater than 29 who underwent cesarean delivery were identified. Of these 238 women, a vertical skin incision was performed in 25 (11%) and a transverse skin incision in 213 (89%). The overall incidence of wound complications in this group was 13%. BMI was associated with wound complications (p < 0.01). After controlling for confounding factors, no difference in wound complication based on type of skin incision was apparent. The type of skin incision does not appear to be associated with wound complications in the obese parturient; however, larger studies would be needed to confirm this finding. Increased BMI is associated with a higher rate of wound complications.


Asunto(s)
Cesárea/métodos , Obesidad/complicaciones , Dehiscencia de la Herida Operatoria , Adulto , Índice de Masa Corporal , Estudios de Cohortes , Femenino , Humanos , Embarazo , Estudios Retrospectivos
2.
J Am Dent Assoc ; 142(11): 1275-82, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22041414

RESUMEN

BACKGROUND: Racial or ethnic and economic disparities exist in terms of oral diseases among pregnant women and children. The authors hypothesized that women of a racial or ethnic minority have less oral health knowledge than do women not of a racial or ethnic minority. Therefore, the authors conducted a study to assess and compare maternal oral health knowledge and beliefs and to determine if maternal race and ethnicity or other maternal factors contributed to women's knowledge or beliefs. METHODS: The authors administered a written oral health questionnaire to pregnant women. The authors calculated the participants' knowledge and belief scores on the basis of correct answers or answers supporting positive oral health behaviors. They conducted multivariable analysis of variance to assess associations between oral health knowledge and belief scores and characteristics. RESULTS: The authors enrolled 615 women in the study, and 599 (97.4 percent) completed the questionnaire. Of 599 participants, 573 (95.7 percent) knew that sugar intake is associated with caries. Almost one-half (295 participants [49.2 percent]) did not know that caries and periodontal disease are oral infections. Median (interquartile range) knowledge and belief scores were 6.0 (5.5-7.0) and 6.0 (5.0-7.0), respectively. Hispanic women had median (interquartile range) knowledge and belief scores significantly lower than those of white or African American women (6.0 [4.0-7.0] versus 7.0 [6.0-7.0] versus 7.0 [6.0-7.0], respectively [P < .001]; and 5.0 [4.0-6.0] versus 6.0 [5.0-7.0] versus 6.0 [5.0-7.0], respectively [P < .001]). Multivariable analysis of variance results showed that being of Hispanic ethnicity was associated significantly with a lower knowledge score, and that an education level of eighth grade or less was associated significantly with a lower belief score. CONCLUSIONS: Pregnant women have some oral health knowledge. Knowledge varied according to maternal race or ethnicity, and beliefs varied according to maternal education. Including oral health education as a part of prenatal care may improve knowledge regarding the importance of oral health among vulnerable pregnant women, thereby improving their oral health and that of their children. CLINICAL IMPLICATIONS: Including oral health education as a part of prenatal care should be considered.


Asunto(s)
Actitud Frente a la Salud , Conocimientos, Actitudes y Práctica en Salud , Salud Bucal , Embarazo/psicología , Adulto , Negro o Afroamericano/psicología , Asiático/psicología , Cariostáticos/uso terapéutico , Caries Dental/etiología , Caries Dental/microbiología , Sacarosa en la Dieta/efectos adversos , Escolaridad , Etnicidad/psicología , Femenino , Fluoruros/uso terapéutico , Conductas Relacionadas con la Salud , Hispánicos o Latinos/psicología , Humanos , Renta , Cobertura del Seguro , Estado Civil , Conducta Materna , North Carolina , Higiene Bucal , Enfermedades Periodontales/microbiología , Encuestas y Cuestionarios , Población Blanca/psicología
3.
J Med Chem ; 52(23): 7678-88, 2009 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-19634903

RESUMEN

Doxazolidine (Doxaz) is a functionally distinct formaldehyde conjugate of doxorubicin (Dox) that induces cancer cell death in Dox-sensitive and resistant cells. Pentyl PABC-Doxaz (PPD) is a prodrug of Doxaz that is activated by carboxylesterase 2 (CES2), which is expressed by liver, non-small-cell lung, colon, pancreatic, renal, and thyroid cancer cells. Here, we demonstrate that in two murine models, PPD was effective at slowing tumor growth and demonstrated markedly reduced cardiotoxic and nephrotoxic effects, as well as better tolerance, relative to Dox. Hepatotoxicity, consistent with liver expression of the murine CES2 homologue, was induced by PPD. Unlike irinotecan, a clinical CES2-activated prodrug, PPD produced no visible gastrointestinal damage. Finally, we demonstrate that cellular response to PPD may be predicted with good accuracy using CES2 expression and Doxaz sensitivity, suggesting that these metrics may be useful as clinical biomarkers for sensitivity of a specific tumor to PPD treatment.


Asunto(s)
Carbamatos/metabolismo , Carbamatos/farmacología , Carboxilesterasa/metabolismo , Doxorrubicina/análogos & derivados , Oxazoles/metabolismo , Profármacos/metabolismo , Profármacos/farmacología , Animales , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Western Blotting , Carbamatos/química , Carbamatos/toxicidad , Carboxilesterasa/genética , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Doxorrubicina/química , Doxorrubicina/metabolismo , Doxorrubicina/farmacología , Doxorrubicina/toxicidad , Evaluación Preclínica de Medicamentos , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Ratones , Miocitos Cardíacos/efectos de los fármacos , Neoplasias/enzimología , Neoplasias/patología , Oxazoles/farmacología , Profármacos/química , Profármacos/toxicidad , Ratas , Análisis de Regresión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA